Rigel Pharmaceuticals
RIGL
#6937
Rank
ยฃ0.51 B
Marketcap
ยฃ27.59
Share price
-0.22%
Change (1 day)
81.45%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): ยฃ95.01 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.29 Billion. In 2025 the company made an earning of ยฃ96.96 Million, an increase over its 2024 earnings that were of ยฃ19.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ95.01 M-2.01%
2025 ยฃ96.96 M391.35%
2024 ยฃ19.73 M-244.27%
2023 -ยฃ13.68 Million-66.79%
2022 -ยฃ41.2 Million340.73%
2021 -ยฃ9.35 Million-56.15%
2020 -ยฃ21.32 Million-57.34%
2019 -ยฃ49.98 Million-7.66%
2018 -ยฃ54.12 Million-9.47%
2017 -ยฃ59.78 Million24.46%
2016 -ยฃ48.04 Million23.63%
2015 -ยฃ38.86 Million-43.29%
2014 -ยฃ68.52 Million2.5%
2013 -ยฃ66.85 Million
2010 ยฃ28.42 M-133.97%
2009 -ยฃ83.68 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ59.72 Million84.74%
2006 -ยฃ32.33 Million-10.17%
2005 -ยฃ35.99 Million-15.73%
2004 -ยฃ42.7 Million39.29%
2003 -ยฃ30.66 Million10.3%
2002 -ยฃ27.8 Million48.3%
2001 -ยฃ18.75 Million-2.13%
2000 -ยฃ19.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ6.82 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ11.01 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ82.84 Million-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-ยฃ98.06 Million-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA